Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adults

Neurocrine Biosciences has commenced the Phase I clinical trial of its oral, small molecule vesicular monoamine transporter 2 (VMAT2) inhibitor, NBI-1140675 in healthy adults.